{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:39:53Z","timestamp":1707525593275},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,14]]},"DOI":"10.7759\/cureus.50536","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:56:40Z","timestamp":1702601800000},"source":"Crossref","is-referenced-by-count":0,"title":["Mantle Cell Lymphoma Presenting as Cholecystitis and Nephromegaly"],"prefix":"10.7759","author":[{"given":"Kamen W","family":"Kossow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aung M","family":"Tun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Kribs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Mantle cell lymphoma","author":"Lynch D","year":"2023","unstructured":"Lynch D, Koya S, Acharya U, et al.. Mantle cell lymphoma. StatPearls. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2014.34.191","article-title":"Mantle cell lymphoma: biology, clinical presentation, and therapeutic approaches","author":"Dreyling M","year":"2014","unstructured":"Dreyling M. Mantle cell lymphoma: biology, clinical presentation, and therapeutic approaches. Am Soc Clin Oncol Educ Book. 2014, 191-8. 10.14694\/EdBook_AM.2014.34.191","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11096","article-title":"Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma","volume":"97","author":"Romaguera JE","year":"2003","unstructured":"Romaguera JE, Medeiros LJ, Hagemeister FB, et al.. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer. 2003, 97:586-91. 10.1002\/cncr.11096","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239740","article-title":"Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinations","volume":"15","author":"Lee HH","year":"2020","unstructured":"Lee HH, Cho SG, Lee IS, et al.. Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinations. PLoS One. 2020, 15:e0239740. 10.1371\/journal.pone.0239740","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00394-z","article-title":"Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma","volume":"11","author":"Castellino A","year":"2021","unstructured":"Castellino A, Tun AM, Wang Y, et al.. Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma. Blood Cancer J. 2021, 11:8. 10.1038\/s41408-020-00394-z","journal-title":"Blood Cancer J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000208899.15859.cb","article-title":"Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study","volume":"30","author":"Salar A","year":"2006","unstructured":"Salar A, Juanpere N, Bellosillo B, et al.. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol. 2006, 30:1274-80. 10.1097\/01.pas.0000208899.15859.cb","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181e9bb8b","article-title":"Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications","volume":"34","author":"Mani H","year":"2010","unstructured":"Mani H, Climent F, Colomo L, Pittaluga S, Raffeld M, Jaffe ES. Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications. Am J Surg Pathol. 2010, 34:1277-86. 10.1097\/PAS.0b013e3181e9bb8b","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13876","article-title":"Clinicopathological features of Chinese patients with B-cell lymphoproliferative disorders and kidney infiltration","volume":"26","author":"Cheung CY","year":"2021","unstructured":"Cheung CY, Tang AH, Wong YT, Chan GS, Tang SC. Clinicopathological features of Chinese patients with B-cell lymphoproliferative disorders and kidney infiltration. Nephrology (Carlton). 2021, 26:650-8. 10.1111\/nep.13876","journal-title":"Nephrology (Carlton)"},{"key":"ref9","article-title":"Renal lymphoma","author":"Bokhari M","year":"2023","unstructured":"Bokhari M, Rana U, Bokhari S. Renal lymphoma. StatPearls. StatPearls Publishing, Treasure Island; 2023."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrpr.2016.11.006","article-title":"Mantle cell lymphoma presented as enteric intussusception and involved gallbladder","volume":"4","author":"Chin C","year":"2017","unstructured":"Chin C, Shiau J, Wu W . Mantle cell lymphoma presented as enteric intussusception and involved gallbladder. J Cancer Res Pract. 2017, 4:105-8. 10.1016\/j.jcrpr.2016.11.006","journal-title":"J Cancer Res Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000594596.43716.40","article-title":"Recurrent mantle cell lymphoma to the gall bladder: a peculiar PET CT","volume":"114","author":"Datta S","year":"2019","unstructured":"Datta S, Inaganti A, Hilal J, et al.. Recurrent mantle cell lymphoma to the gall bladder: a peculiar PET CT. Am J Gastroenterol. 2019, 114:705-6. 10.14309\/01.ajg.0000594596.43716.40","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201810001-01465","article-title":"Primary gastrointestinal mantle cell lymphoma involving colon and gallbladder: a case report","volume":"113","author":"Prakash S","year":"2018","unstructured":"Prakash S, Siddiqui S, Ashangari C, et al.. Primary gastrointestinal mantle cell lymphoma involving colon and gallbladder: a case report. Am J Gastroenterol. 2018, 113:839-41.","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2011.00612.x","article-title":"Renal involvement of mantle cell lymphona leading to end stage renal disease","volume":"16","author":"Lee HJ","year":"2012","unstructured":"Lee HJ, Seo JW, Cho HS, et al.. Renal involvement of mantle cell lymphona leading to end stage renal disease. Hemodial Int. 2012, 16:104-8. 10.1111\/j.1542-4758.2011.00612.x","journal-title":"Hemodial Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/23993693211039870","article-title":"Renal lymphomatous infiltration by mantle cell lymphoma: treatment with chemoradiation and initiation of angiotensin converting enzyme (ACE) inhibitor for renal protection","volume":"5","author":"Damron E","year":"2021","unstructured":"Damron E, Gunther J, Kala J. Renal lymphomatous infiltration by mantle cell lymphoma: treatment with chemoradiation and initiation of angiotensin converting enzyme (ACE) inhibitor for renal protection. J Onconephrol. 2021, 5:183-7. 10.1177\/23993693211039870","journal-title":"J Onconephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03470-z","article-title":"Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report","volume":"16","author":"Nassereldine H","year":"2022","unstructured":"Nassereldine H, Mohty R, Awada H, Abou Dalle I, El-Cheikh J, Bazarbachi A. Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report. J Med Case Rep. 2022, 16:254. 10.1186\/s13256-022-03470-z","journal-title":"J Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.10386","article-title":"Gallbladder wall thickening","volume":"202","author":"Runner GJ","year":"2014","unstructured":"Runner GJ, Corwin MT, Siewert B, Eisenberg RL. Gallbladder wall thickening. AJR Am J Roentgenol. 2014, 202:W1-W12. 10.2214\/AJR.12.10386","journal-title":"AJR Am J Roentgenol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.53347\/rID-17101","article-title":"Bilateral renal enlargement","author":"Jha P","year":"2023","unstructured":"Jha P, Weerakkody Y, Bell D, et al.. Bilateral renal enlargement. Radiopaedia. 2023, 10.53347\/rID-17101","journal-title":"Radiopaedia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-27532-1_8","article-title":"Cervical: lymphadenopathy","author":"Sakr M","year":"2016","unstructured":"Sakr M. Cervical: lymphadenopathy. Head and Neck and Endocrine Surgery. Sakr M (ed): Springer, Cham; 2016. 163-90. 10.1007\/978-3-319-27532-1_8"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02287","article-title":"High-risk mantle cell lymphoma: definition, current challenges, and management","volume":"38","author":"Jain P","year":"2020","unstructured":"Jain P, Dreyling M, Seymour JF, Wang M. High-risk mantle cell lymphoma: definition, current challenges, and management. J Clin Oncol. 2020, 38:4302-16. 10.1200\/JCO.20.02287","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14699","article-title":"Incidence and survival trends in mantle cell lymphoma","volume":"181","author":"Epperla N","year":"2018","unstructured":"Epperla N, Hamadani M, Fenske TS, Costa LJ. Incidence and survival trends in mantle cell lymphoma. Br J Haematol. 2018, 181:703-6. 10.1111\/bjh.14699","journal-title":"Br J Haematol"},{"key":"ref21","article-title":"Corticosteroids in the treatment of neoplasm","author":"McKay L","year":"2003","unstructured":"McKay L, Cidlowski J  . Corticosteroids in the treatment of neoplasm. Holland-Frei Cancer Medicine. 6th edition. Kufe DW, Pollock RE, Weichselbaum RR, et al. (ed): BC Decker, Hamilton; 2003. 163-90."},{"key":"ref22","unstructured":"Mantle Cell Lymphoma. NCCN Guidelines Recommendations (version 4.2023). (2023). https.\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/Mantle-patient-guideline.pdf."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.9842","article-title":"Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation","volume":"31","author":"Visco C","year":"2013","unstructured":"Visco C, Finotto S, Zambello R, et al.. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. J Clin Oncol. 2013, 31:1442-9. 10.1200\/JCO.2012.45.9842","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-791392","article-title":"Update on mantle cell lymphoma","volume":"132","author":"Maddocks K","year":"2018","unstructured":"Maddocks K. Update on mantle cell lymphoma. Blood. 2018, 132:1647-56. 10.1182\/blood-2018-03-791392","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/199408-mantle-cell-lymphoma-presenting-as-cholecystitis-and-nephromegaly","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:30Z","timestamp":1707509430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/199408-mantle-cell-lymphoma-presenting-as-cholecystitis-and-nephromegaly"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.50536","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,14]]}}}